 |
|
|
| |
Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study
|
| |
| |
AIDS 2022 July 29- Aug 1 Montreal
Presenter
Hernando Knobel
Authors
H. Knobel * (1), E. Canas (1), A. Guelar (1), J. Villar (1), A. González (1), C. Canepa (1), I. Arrieta (1), A. Marcos (1), R. Güerri (1)
Institutions
(1) Hospital del Mar, Infectious Diseases, Barcelona, Spain
|
| |
|
|
|
|
|
